Xiangdong Liu
Inner Mongolia Agricultural University(CN)Institute of Grassland Research(CN)University at Buffalo, State University of New York(US)
Publications by Year
Research Areas
Tryptophan and brain disorders, Cancer-related molecular mechanisms research, CRISPR and Genetic Engineering, Mycotoxins in Agriculture and Food, Viral Infections and Immunology Research
Most-Cited Works
- → Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci(2010)1,270 cited
- → Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity(2010)552 cited
- → Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR(2014)305 cited
- → INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology(2017)291 cited
- → Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model(2009)216 cited
- → A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer